Research map: Functional anti-preS1 antibody responses associated with viral control in chronic hepatitis B

Back to the article

Papers in this map

  1. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus · Huan Yan · 2012 · 2154 citations · Cited by this paper
  2. A patient-driven agenda for liver cirrhosis research · 2026 · Related
  3. Hepatitis B virus infection · CHRISTIAN TREPO · 2014 · 1649 citations · Cited by this paper
  4. International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials · 2026 · Related
  5. Beyond binding: antibody effector functions in infectious diseases · Lenette L. Lu · 2017 · 887 citations · Cited by this paper
  6. Toward a CKLM framework for integrated clinical trial design · 2026 · Related
  7. Hepatitis B · Wen‐Juei Jeng · 2023 · 581 citations · Cited by this paper
  8. Large language models for detecting colorectal polyps in endoscopic images—further research is required · 2026 · Related
  9. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus · A. ROBERT NEURATH · 1986 · 527 citations · Cited by this paper
  10. USP20 promotes CD8 + T cell exhaustion and impairs KRAS G12D inhibitor efficacy by orchestrating cholesterol metabolism and autophagy in pancreatic cancer · 2026 · Related
  11. Immunobiology and pathogenesis of hepatitis B virus infection · Matteo Iannacone · 2021 · 522 citations · Cited by this paper
  12. Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification · 2026 · Related
  13. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study · Devin Razavi‐Shearer · 2023 · 441 citations · Cited by this paper
  14. Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control · 2026 · Related
  15. Circulating and intrahepatic antiviral B cells are defective in hepatitis B · Alice R. Burton · 2018 · 339 citations · Cited by this paper
  16. Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality · 2026 · Related
  17. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients · Barbara Testoni · 2018 · 311 citations · Cited by this paper
  18. Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study · 2026 · Related
  19. Discontinuation of oral antivirals in chronic hepatitis B: A systematic review · George Papatheodoridis · 2016 · 281 citations · Cited by this paper
  20. Understanding HBV immunopathogenesis to inform future immune-based therapies · 2026 · Related
  21. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis · Yee Hui Yeo · 2018 · 274 citations · Cited by this paper
  22. Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction · Andreas Schulze · 2009 · 242 citations · Cited by this paper
  23. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease · Stephan Urban · 2021 · 241 citations · Cited by this paper
  24. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook · Anna Kramvis · 2022 · 188 citations · Cited by this paper
  25. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. · David R. Milich · 1986 · 184 citations · Cited by this paper
  26. Ubiquitous expression of HBsAg from integrated HBV DNA in patients with low viral load · Marie‐Anne Meier · 2021 · 158 citations · Cited by this paper
  27. A potent human neutralizing antibody Fc-dependently reduces established HBV infections · Dan Li · 2017 · 125 citations · Cited by this paper
  28. The replication cycle of hepatitis B virus · Stephan Urban · 2009 · 121 citations · Cited by this paper
  29. Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome · Fabien Zoulim · 2024 · 120 citations · Cited by this paper
  30. Hepatitis D · Francesco Negro · 2023 · 117 citations · Cited by this paper
  31. Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand · Mala K. Maini · 2018 · 96 citations · Cited by this paper
  32. Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling · Jieliang Chen · 2020 · 85 citations · Cited by this paper
  33. A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations · Qiao Wang · 2020 · 79 citations · Cited by this paper
  34. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. · Carlo I. Ferrari · 1989 · 76 citations · Cited by this paper
  35. An Antibody Which Precipitates Dane Particles in Acute Hepatitis Type B: Relation to Receptor Sites Which Bind Polymerized Human Serum Albumin on Virus Particles · Alfredo Alberti · 1984 · 70 citations · Cited by this paper
  36. Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV · Thomas Vanwolleghem · 2020 · 69 citations · Cited by this paper
  37. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population · Zhigang Yi · 2020 · 68 citations · Cited by this paper
  38. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B · Barbara Testoni · 2023 · 61 citations · Cited by this paper
  39. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg‐negative chronic hepatitis B · George Papatheodoridis · 2017 · 60 citations · Cited by this paper

Source: OpenAlex (CC0)